Papers: 10.1186/s12957-020-02017-0

https://doi.org/10.1186/s12957-020-02017-0

The combination therapy of transarterial chemoembolisation and sorafenib is the preferred palliative treatment for advanced hepatocellular carcinoma patients: a meta-analysis

Cited by: 16
Author(s): Zhoujing Cheng, Lin He, Yingjie Guo, Yuhua Song, Shasha Song, Lijiu Zhang
Published: about 6 years ago

Software Mentions 1